abstract |
The present invention relates to a pharmaceutical composition for oral administration of dabigatran etexilate or pharmaceutically acceptable salts thereof wherein the composition comprises a pellet core surrounded by active substance layers, water soluble isolating layers, an acid layer, and an isolating layer, and processes for the preparation thereof. |